The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
about
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so farDoes Cannabidiol Protect Against Adverse Psychological Effects of THC?Marijuana, the Endocannabinoid System and the Female Reproductive SystemExpression and Function of the Endocannabinoid System in the Retina and the Visual BrainTowards a personalized treatment in depression: endocannabinoids, inflammation and stress responseEndocannabinoids are Involved in Male Vertebrate Reproduction: Regulatory Mechanisms at Central and Gonadal LevelNMR solution structure of human cannabinoid receptor-1 helix 7/8 peptide: Candidate electrostatic interactions and microdomain formation(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2Identification of Yju3p as functional orthologue of mammalian monoglyceride lipase in the yeast Saccharomycescerevisiae.Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding PocketsEmerging targets in lipid-based therapyTerpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systemsCannabinoids, eating behaviour, and energy homeostasis.Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation.Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance.Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdalaSubstrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activationEndogenous cannabinoid signaling at inhibitory interneurons.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceA covering method for detecting genetic associations between rare variants and common phenotypes.hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation.CB1 allosteric modulator Org27569 is an antagonist/inverse agonist of ERK1/2 signaling.Identification of palmitoyl protein thioesterase 1 in human THP1 monocytes and macrophages and characterization of unique biochemical activities for this enzymeEndocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling.Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?Endocannabinoid signaling and synaptic function.HPLC-MS-MS Determination of ZCZ-011, A Novel Pharmacological Tool for Investigation of the Cannabinoid Receptor in Mouse Brain Using Clean Screen FASt™ Column Extraction.New insights on the role of the endocannabinoid system in the regulation of energy balance.Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.Suppression of CB1 cannabinoid receptor by lentivirus mediated small interfering RNA ameliorates hepatic fibrosis in rats.Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.Human cannabinoid 1 GPCR C-terminal domain interacts with bilayer phospholipids to modulate the structure of its membrane environment.Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemiaThe major central endocannabinoid directly acts at GABA(A) receptors.Endocannabinoids and diacylglycerol kinase activity.Lipoxygenase-mediated oxidation of polyunsaturated N-acylethanolamines in ArabidopsisMonoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance.
P2860
Q21090468-1820A20C-F056-4EC1-A6DF-532D9DB3A0D5Q21129107-D32A61FC-91D9-4682-A585-E8887AC6563FQ26746181-34F9B80A-F056-47CA-93C8-32623D6A3EB1Q26769951-4428CBF7-1CF5-4210-B1A0-C4649467344BQ26851511-D7A423C8-5930-4C96-BF02-70CBC1A800D9Q26864201-E66A2551-6377-4A53-886B-178DB92DA780Q27657475-FACC9A1E-2692-4226-A87C-DF1BB24DD9C7Q27675386-6ACC0EA3-F75D-4ADE-A49D-DF6608ABD11AQ27936792-D3FA30AB-8F27-4F5D-8A30-9CFCE5572505Q28548681-CF197FEC-2BFF-4EDA-B114-6EE6B804B39DQ28655456-98CDD263-8EA8-42F4-890A-135EC7F43147Q28829964-42D6DFCA-6614-4AE8-8943-9904995DB980Q30357350-E70050B0-322F-4D89-8B5A-382E664936D5Q30406301-FE214458-D6E3-4AC2-8B3C-17BCA6E36D49Q30471167-287B037E-275D-4DC5-9E9E-3C5DB448A794Q30498563-20606762-C4F5-4EB2-AA89-3AAB3F6871E7Q30547823-3564690C-AACB-4849-8F21-9A77EB555589Q33624983-86DE4C0C-9A21-4BD2-BFEA-CAEAF9C62781Q33703839-DEADDA39-9502-4468-9FFA-6F25A9E61C71Q33728635-F3936E18-C6C1-4CAB-8878-38CFAD96CC8EQ33733994-DEDA0021-EED6-4B14-8B91-1076547A7031Q33833528-66411A47-3E8E-4475-A518-31C51211EA84Q33917127-8737954A-D515-4FF2-AC9D-5BC9E5C75495Q33997873-A8FEDEB0-4C99-4C51-BA80-142F16E056CBQ34145142-7E89F368-D96B-4B21-A5FA-D1AFD2DF76FDQ34157484-EE4DE4B7-0C5F-475F-BA37-C80F5EF4BD02Q34173626-09E98BCF-6E03-428D-BF6F-60ED605CAD44Q34304094-385A13B8-DEF6-4F01-BD91-1FBAF69EECC8Q34465562-0385EF6D-C50A-4EB8-870A-21E81348F24FQ34494301-A32917C6-8849-4193-B479-1EABC4F1FC16Q34495550-4F352046-EAFA-4343-9DF3-CC005E9D60F4Q34515920-89A620F5-B426-42A1-8F0B-3421F14CF56DQ34534861-B70D89BF-15B8-4E0E-A824-5FD48F9A41E6Q34544573-80CAB5D4-5A6A-4AC9-BEC6-CF50469714B9Q34563482-3CDF841F-05DE-40A6-9CA9-A73A198B9181Q34581048-35DC5E71-41D7-4AC3-9DED-82BB5599208BQ34660573-F23F7508-E0D0-44EE-8FE5-E7BF0714D27BQ34696352-DA5B2AEA-2604-49C8-80CF-9B9E9F367DA1Q34869154-21A19831-FCE9-4930-B80D-697FD2ECB79AQ34978868-A78B4BFA-E2EF-460A-8BF1-A113477464C1
P2860
The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The endocannabinoid system: it ...... tial therapeutic exploitation.
@en
The endocannabinoid system: it ...... tial therapeutic exploitation.
@nl
type
label
The endocannabinoid system: it ...... tial therapeutic exploitation.
@en
The endocannabinoid system: it ...... tial therapeutic exploitation.
@nl
prefLabel
The endocannabinoid system: it ...... tial therapeutic exploitation.
@en
The endocannabinoid system: it ...... tial therapeutic exploitation.
@nl
P1476
The endocannabinoid system: it ...... tial therapeutic exploitation.
@en
P356
10.1016/J.PHRS.2009.02.010
P577
2009-03-04T00:00:00Z